Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dicker

Showing results (251-260 of 375) with videos related to

Pageof 38
Sort By:
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|January 11, 2014
Umbilical and fetal middle cerebral artery Doppler reference ranges in a twin population followed longitudinally from 24 to 38 weeks' gestationC Mulcahy, F M McAuliffe, F Breathnach, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1999
Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancerR K Valicenti, J W Sweet, W W Hauck, et al.
Journal of Hematology & Oncology|September 25, 2016
Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapyGregory S Alexander, Joshua D Palmer, Madalina Tuluc, et al.
Future Oncology (London, England)|November 25, 2011
Postprostatectomy radiation therapy: an evidence-based reviewMark V Mishra, Colin E Champ, Robert B Den, et al.
Molecular Cancer Therapeutics|February 28, 2013
ALK inhibitor PF02341066 (crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALKYunguang Sun, Kamila A Nowak, Nicholas G Zaorsky, et al.
Irish Journal of Medical Science|December 11, 2013
Evaluation of the effect of intra-operative intravenous fluid on post-operative pain and pulmonary function: a randomized trial comparing 10 and 30 ml kg(-1) of crystalloidB D Straub, A Aslani, K Enohumah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapyRobert B Den, Kasra Yousefi, Edouard J Trabulsi, et al.
Journal of the National Cancer Institute|December 13, 2012
NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizersYaacov Richard Lawrence, Bhadrasain Vikram, James J Dignam, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2015
Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126Kevin L Moore, Rachel Schmidt, Vitali Moiseenko, et al.
Cancer Biology & Therapy|August 7, 2013
Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumabNicholas G Zaorsky, Yunguang Sun, Zixuan Wang, et al.
Pageof 38

Showing results (251-260 of 375) with videos related to

Sort By:
Pageof 38
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|January 11, 2014
Umbilical and fetal middle cerebral artery Doppler reference ranges in a twin population followed longitudinally from 24 to 38 weeks' gestationC Mulcahy, F M McAuliffe, F Breathnach, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1999
Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancerR K Valicenti, J W Sweet, W W Hauck, et al.
Journal of Hematology & Oncology|September 25, 2016
Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapyGregory S Alexander, Joshua D Palmer, Madalina Tuluc, et al.
Future Oncology (London, England)|November 25, 2011
Postprostatectomy radiation therapy: an evidence-based reviewMark V Mishra, Colin E Champ, Robert B Den, et al.
Molecular Cancer Therapeutics|February 28, 2013
ALK inhibitor PF02341066 (crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALKYunguang Sun, Kamila A Nowak, Nicholas G Zaorsky, et al.
Irish Journal of Medical Science|December 11, 2013
Evaluation of the effect of intra-operative intravenous fluid on post-operative pain and pulmonary function: a randomized trial comparing 10 and 30 ml kg(-1) of crystalloidB D Straub, A Aslani, K Enohumah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapyRobert B Den, Kasra Yousefi, Edouard J Trabulsi, et al.
Journal of the National Cancer Institute|December 13, 2012
NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizersYaacov Richard Lawrence, Bhadrasain Vikram, James J Dignam, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2015
Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126Kevin L Moore, Rachel Schmidt, Vitali Moiseenko, et al.
Cancer Biology & Therapy|August 7, 2013
Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumabNicholas G Zaorsky, Yunguang Sun, Zixuan Wang, et al.
Pageof 38